14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PGNX
Delisted

Progenics Pharmaceuticals Inc. Stock Signals

$4.10
+0 (+0%)
At Close: Sep 04, 2020

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 50 days ( 0 % )
Last Price $4.10 0 %
High/ Low $4.10 - $4.10 0%
Chg 7 Days N/A $4.10 $4.10
Chg 30 Days N/A $4.10 $4.10
Chg 12 mos -12.39 % $4.68 $4.10
Trend - 3 mos -4.60 % Width: 21.30 %
Trend - 12 mos -24.03 % Width: 311.98 %
Pred. range - 3 mos $3.60 - $4.37 -12.10 % - 6.63 %
Pred. range - 12 mos $1.00 - $4.11 -75.68 % - 0.192 %
Short MA avg 3 mos Sell Jun 18, 2020 - 56 days
Long MA avg 3 mos Sell Jun 22, 2020 - 54 days
Short/Long MA avg 3 mos Sell Jun 26, 2020 - 50 days
Short MA avg 12 mos Buy Jun 15, 2020 - 59 days
Long MA avg 12 mos Buy Jun 12, 2020 - 60 days
Short/Long MA avg 12 mos Buy Jun 02, 2020 - 68 days
Pivot Short Buy Jun 19, 2020 - 55 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals. Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clinical trial under special protocol assessment for the treatment of pheochromocytoma and paraganglioma; 1404, a technetium-99m labeled small molecule that has completed Phase II testing, as well as acts as an ... PGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT